BHC:NYSE
Bausch Health Companies Inc
$5.80
arrow_upward
+0.52%(+0.030) 1D
$5.80
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 29, 4:00:02 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BHC...
Open
$5.74
High
$5.80
Low
$5.68
Mkt. cap
2.18B
Avg. vol.
2.50M
Volume
1.28M
52-wk high
$8.00
52-wk low
$4.33
EPS
-$2.96
Beta
0.37
Shares outstanding
373.99M
No. of employees
20K
Open
$5.74
High
$5.80
Low
$5.68
Mkt. cap
2.18B
Avg. vol.
2.50M
Volume
1.28M
52-wk high
$8.00
52-wk low
$4.33
EPS
-$2.96
Beta
0.37
Shares outstanding
373.99M
No. of employees
20K
News stories
From web sources and news partners
The Business Journals
·
6 hours ago
New Bausch class action lands in Rhode Island federal court
AD HOC NEWS
·
10 hours ago
Bausch Health Companies stock trades at EUR 5.05 after earnings beat
Zacks
·
1 day ago
Zacks Value Investor Highlights: FOXF, BHC and QNST
Profile
Bausch Health Companies Inc. is a global, diversified Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals.
Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
About Bausch Health Companies Inc
CEOThomas J. Appio
Employees20.3K
Founded1959
HeadquartersLaval, Quebec, Canada
SectorPharmaceutical industry
Websitebauschhealth.com